Oxidative stress-related pathophysiology in chronic rhinosinusitis with nasal polyps: research challenges

1. Fokkens WJ, Lund VJ, Mullol J, Bachert C, Alobid I, Baroody F, et al. European Position Paper on Rhinosinusitis and Nasal Polyps 2012. Rhinol Suppl [Internet]. 2012;23:3 p preceding table of contents, 1-298. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22764607.Search in Google Scholar

2. Newton JR, Ah-See KW. A review of nasal polyposis. Ther Clin Risk Manag. 2008;4(2):507–12.10.2147/TCRM.S2379250406718728843Search in Google Scholar

3. Bengtsson C, Lindberg E, Jonsson L, Holmstrom M, Sundbom F, Hedner J, et al. Chronic rhinosinusitis impairs sleep quality: results of the GA2LEN study. Sleep. 2017;40(1). DOI: 10.1093/sleep/zsw021.10.1093/sleep/zsw02128364469Open DOISearch in Google Scholar

4. Rosenfeld RM, Piccirillo JF, Chandrasekhar SS, Brook I, Ashok Kumar K, Kramper M, et al. Clinical practice guideline (update): adult sinusitis. Otolaryngol Head Neck Surg. 2015;152(2 Suppl):S1–39. DOI: 10.1177/0194599815572097.10.1177/019459981557209725832968Open DOISearch in Google Scholar

5. Bhattacharyya N, Orlandi RR, Grebner J, Martinson M. Cost burden of chronic rhinosinusitis: a claims-based study. Otolaryngol Head Neck Surg. 2011;144(3):440–5. DOI: 10.1177/0194599810391852. Epub 2011 Feb 3.10.1177/0194599810391852.Epub2011Feb3Open DOISearch in Google Scholar

6. Mahdavinia M, Schleimer RP, Keshavarzian A. Sleep disruption in chronic rhinosinusitis. Expert Rev Anti Infect Ther. 2017;15(5):457-65. DOI: 10.1080/14787210.1294063. Epub 2017 Feb 17.10.1080/14787210.1294063.Epub2017Feb17Open DOISearch in Google Scholar

7. Wagenmann M, Scheckenbach K, Chaker AM. Endotypes in chronic rhinosinusitis: biomarkers based on a mechanistic insight for targeted treatment? ORL J Otorhinolaryngol Relat Spec. 2017;79(1–2):78–84. DOI: 10.1159/000455721. Epub 2017 Feb 24.10.1159/000455721.Epub2017Feb24Open DOISearch in Google Scholar

8. Cekin E, Ipcioglu OM, Erkul BE, Kapucu B, Ozcan O, Cincik H, et al. The association of oxidative stress and nasal polyposis. J Int Med Res. 2009;37(2):325–30.1938322510.1177/14732300090370020619383225Search in Google Scholar

9. Cheng YK, Tsai MH, Lin CD, Hwang GY, Hang LW, Tseng GC, et al. Oxidative stress in nonallergic nasal polyps associated with bronchial hyperresponsiveness. Allergy. 2006;61(11):1290–8.10.1111/j.1398-9995.2006.01228.x17002704Search in Google Scholar

10. Bozkus F, San I, Ulas T, Iynen I, Yesilova Y, Guler Y, et al. Evaluation of total oxidative stress parameters in patients with nasal polyps. Acta Otorhinolaryngol Ital. 2013;33(4):248–53.Search in Google Scholar

11. Topal O, Kulaksizoglu S, Erbek SS. Oxidative stress and nasal polyposis: does it affect the severity of the disease? Am J Rhinol Allergy. 2014;28(1):e1-4. DOI: 10.2500/ajra.2014.28.3963.10.2500/ajra.2014.28.396324717866Open DOISearch in Google Scholar

12. Holecek V, Rokyta R, Slipka J. Free radicals in nasal and paranasal diseases. In: Miller J, Le Prell CG, Rybak L, editors. Free radicals in ENT pathology. Humana Press; 2015, p.479–92.10.1007/978-3-319-13473-4_24Search in Google Scholar

13. Esmatinia F, Bakhshaei M. Recurrent sinonasal polyposis after the endoscopic sinus surgery. Rev Clin Med. 2014;1(2):86-92. DOI: 10.17463/RCM.2014.02.010.10.17463/RCM.2014.02.010Open DOISearch in Google Scholar

14. Burgess A, Shah K, Hough O, Hynynen K. Focused ultrasound-mediated drug delivery through the blood-brain barrier. Expert Rev Neurother. 2015;15(5):477–91. DOI: 10.1586/14737175.2015.1028369.10.1586/14737175.2015.1028369470226425936845Open DOISearch in Google Scholar

15. Cheng YK, Hwang GY, Lin CD, Tsai MH, Tsai SW, Chang WC. Altered expression profile of superoxide dismutase isoforms in nasal polyps from nonallergic patients. Laryngoscope. 2006;116(3):417–22.10.1097/01.MLG.0000199738.37455.5516540901Search in Google Scholar

16. Dagli M, Eryilmaz A, Besler T, Akmansu H, Acar A, Korkmaz H. Role of free radicals and antioxidants in nasal polyps. Laryngoscope. 2004;114(7):1200–3.10.1097/00005537-200407000-0001315235348Search in Google Scholar

17. Sagit M, Erdamar H, Saka C, Yalcin S, Akin I. Effect of antioxidants on the clinical outcome of patients with nasal polyposis. J Laryngol Otol. 2011;125(08):811–5. DOI: 10.1017/S0022215111001149. Epub 2011 Jun 14.10.1017/S002221511100114921669016Search in Google Scholar

18. Bozkus F, Ulas T, San I, Yesilova Y, Iynen I, Guldur ME, et al. Evaluation of ceruloplasmin levels in patients undergoing surgical interventions with nasal polyps. Auris Nasus Larynx. 2013;40(3):282–5. DOI: 10.1016/j.anl.2012.07.018. Epub 2012 Oct 30.10.1016/j.anl.2012.07.018.Epub2012Oct30Open DOISearch in Google Scholar

19. Yu Z, Wang Y, Zhang J, Li L, Wu X, Ma R, et al. Expression of heme oxygenase-1 in eosinophilic and non-eosinophilic chronic rhinosinusitis with nasal polyps: modulation by cytokines. Int Forum Allergy Rhinol. 2015;5(8):734-40. DOI: 10.1002/alr.21530. Epub 2015 Apr 23.10.1002/alr.21530.Epub2015Apr23Open DOISearch in Google Scholar

20. Taysi S, Uslu C, Yilmaz A, Aktan B, Altas E. Lipid peroxidation and some antioxidant enzymes in nasal polyp tissue. Cell Biochem Funct. 2006;24(5):461–5.10.1002/cbf.130316287205Open DOISearch in Google Scholar

21. Kirtsreesakul V. Update on nasal polyps: etiopathogenesis. J Med Assoc Thail. 2005;88(12):1966–72.Search in Google Scholar

22. Assanasen P. Medical and surgical management of nasal polyps. Curr Opin Otolaryngol Head Neck Surg. 2016;9(1):27–36.10.1097/00020840-200102000-00007Search in Google Scholar

23. Lopez-Chacon M, Mullol J, Pujols L. Clinical and biological markers of difficult-to-treat severe chronic rhinosinusitis. Curr Allergy Asthma Rep. 2015;15(5):19. DOI: 10.1007/s11882-015-0520-6.10.1007/s11882-015-0520-626134430Open DOISearch in Google Scholar

24. Duda R. The role of inflammatory mediators in the pathogenesis of nasal polyposis: Literature review. Rom J Rhinol. 2015;5(18):81–5. DOI: 10.1515/rjr-2015-0009.10.1515/rjr-2015-0009Open DOISearch in Google Scholar

25. Önerci MT, Ferguson BJ. Nasal polyposis: Pathogenesis, medical and surgical treatment. Springer Science & Business Media; 2010.10.1007/978-3-642-11412-0Search in Google Scholar

26. Akyigit A, Keles E, Etem EO, Ozercan I, Akyol H, Sakallioglu O, et al. Genetic polymorphism of antioxidant enzymes in eosinophilic and non-eosinophilic nasal polyposis. Eur Arch Otorhinolaryngol. 2017;274(1):267–73. DOI: 10.1007/s00405-016-4259-z. Epub 2016 Aug 11.10.1007/s00405-016-4259-z.Epub2016Aug11Open DOISearch in Google Scholar

27. Lee JM, McKnight CL, Aves T, Yip J, Grewal AS, Gupta S. Nasal nitric oxide as a marker of sinus mucosal health in patients with nasal polyposis. Int Forum Allergy Rhinol. 2015;5(10):894–9. DOI: 10.1002/alr.21598. Epub 2015 Jul 17.10.1002/alr.21598.Epub2015Jul17Open DOISearch in Google Scholar

28. Egea J, Fabregat I, Frapart YM, Ghezzi P, Görlach A, Kietzmann T, et al. Corrigendum to “European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EUROS)” [Redox Biol. 13 (2017) 94–162]. Redox Biol. 2018;14:694–6. DOI: 10.1016/j.redox.2017.10.001. Epub 2017 Oct 26.10.1016/j.redox.2017.10.001.Epub2017Oct26Open DOISearch in Google Scholar

29. Birben E, Sahiner UM, Sackesen C, Erzurum S, Kalayci O. Oxidative stress and antioxidant defense. World Allergy Organ J. 2012;5(1):9–19. DOI: 10.1097/WOX.0b013e3182439613. Epub 2012 Jan 13.10.1097/WOX.0b013e3182439613.Epub201213Open DOISearch in Google Scholar

30. Lobo V, Patil A, Phatak A, Chandra N. Free radicals, antioxidants and functional foods: Impact on human health. Pharmacogn Rev. 2010 Jul;4(8):118–26.10.4103/0973-7847.70902324991122228951Search in Google Scholar

31. Asher BF, Guilford FT. Oxidative stress and low glutathione in common ear, nose, and throat conditions: A systematic review. Altern Ther Health Med. 2016;22(5):44–50.Search in Google Scholar

32. Arild Danielsen K, Eskeland Ø, Fridrich-Aas K, Cecilie Orszagh V, Bachmann-Harildstad G, Burum-Auensen E. Bacterial biofilms in chronic rhinosinusitis; distribution and prevalence. Acta Otolaryngol. 2016;136(1):109–12. DOI: 10.3109/00016489.2015.1092169. Epub 2015 Sep 25.10.3109/00016489.2015.1092169.Epub2015Sep25Open DOISearch in Google Scholar

33. Norlander T, Fukami M, Westrin KM, Stierna P, Carlsöö B. Formation of mucosal polyps in the nasal and maxillary sinus cavities by infection. Otolaryngol Head Neck Surg. 1993;109(3 Pt 1):522-9.10.1177/0194599893109003228414573Search in Google Scholar

34. Wladislavosky-Waserman P, Kern EB, Holley KE, Eisenbrey AB, Gleich GJ. Epithelial damage in nasal polyps. Clin Allergy. 1984;14(3):241–7.10.1111/j.1365-2222.1984.tb02203.x6733889Open DOISearch in Google Scholar

35. Carey RM, Workman AD, Chen B, Adappa ND, Palmer JN, Kennedy DW, et al. Staphylococcus aureus triggers nitric oxide production in human upper airway epithelium. Int Forum Allergy Rhinol. 2015;5(9):808–13. DOI: 10.1002/alr.21568. Epub 2015 Jun 22.10.1002/alr.21568.Epub2015Jun22Open DOISearch in Google Scholar

36. Tamashiro E, Banks CA, Cohen NA. New Areas for Investigation: Nitric Oxide. In: Önerci TM, Ferguson BJ, editors. Nasal Polyposis: Pathogenesis, Medical and Surgical Treatment. Springer-Verlag Berlin Heidelberg; 2010, p.175-83.10.1007/978-3-642-11412-0_20Search in Google Scholar

37. Carey RM, Chen B, Adappa ND, Palmer JN, Kennedy DW, Lee RJ, et al. Human upper airway epithelium produces nitric oxide in response to Staphylococcus epidermidis. Int Forum Allergy Rhinol. 2016;6(12):1238–44. DOI: 10.1002/alr.21837. Epub 2016 Aug 10.10.1002/alr.21837.Epub2016Aug10Open DOISearch in Google Scholar

38. Cho DY, Le W, Bravo DT, Hwang PH, Illek B, Fischer H, et al. Air pollutants cause release of hydrogen peroxide and interleukin-8 in a human primary nasal tissue culture model. Int Forum Allergy Rhinol. 2014;4(12):966–71. DOI: 10.1002/alr.21413. Epub 2014 Nov 14.10.1002/alr.2141325400124Search in Google Scholar

39. Smith KA, Rudmik L. Medical therapy, refractory chronic rhinosinusitis, and productivity costs. Curr Opin Allergy Clin Immunol. 2017;17(1):5–11. DOI: 10.1097/ACI.0000000000000329.10.1097/ACI.000000000000032927906696Open DOISearch in Google Scholar

40. Passali D, Cingi C, Cambi J, Passali F, Muluk NB, Bellussi ML. A survey on chronic rhinosinusitis: opinions from experts of 50 countries. Eur Arch Otorhinolaryngol. 2016;273(8):2097–109. DOI: 10.1007/s00405-015-3880-6. Epub 2016 Jan 7.10.1007/s00405-015-3880-626742909Search in Google Scholar

41. Chong LY, Head K, Hopkins C, Philpott C, Schilder AGM, Burton MJ. Intranasal steroids versus placebo or no intervention for chronic rhinosinusitis. Cochrane Database Syst Rev. 2016;4:CD011996. DOI: 10.1002/14650858. CD011996.pub.2.10.1002/14650858.CD011996.pub.2Open DOISearch in Google Scholar

42. Kohanski MA, Tharakan A, Lane AP, Ramanathan M Jr. Bactericidal antibiotics promote reactive oxygen species formation and inflammation in human sinonasal epithelial cells. Int Forum Allergy Rhinol. 2016;6(2):191–200. DOI: 10.1002/alr.21646. Epub 2015 Dec 1.10.1002/alr.21646.Epub2015Dec1Open DOISearch in Google Scholar

43. Yu MS, Kim BH, Kang SH, Lim DJ. Low-concentration hypochlorous acid nasal irrigation for chronic sinonasal symptoms: a prospective randomized placebo-controlled study. Eur Arch Otorhinolaryngol. 2017;274(3):1527–33. DOI: 10.1007/s00405-016-4387-5. Epub 2016 Nov 17.10.1007/s00405-016-4387-5.Epub2016Nov17Open DOISearch in Google Scholar

44. Veyseller B, Aksoy E, Ertas B, Keskin M, Ozturan O, Yildirim YS, et al. A new oxidative stress marker in patients with nasal polyposis: advanced oxidation protein products (AOPP). B-ENT. 2010;6(2):105–9.Search in Google Scholar